New study aims to reduce brain fog after radiation for skull tumors

NCT ID NCT05895344

Recruiting now Knowledge-focused Sponsor: Centre Francois Baclesse Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at two types of radiation therapy for a slow-growing brain tumor near the cavernous sinus. Researchers want to see if proton therapy causes less long-term harm to thinking and memory than standard photon radiation. About 160 adults aged 18 to 70 will be followed for years after treatment. The goal is to find out which method better protects brain function over time.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CAVERNOUS SINUS MENINGIOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cavernous sinus meningioma Cognitive Dysfunction

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CAVERNOUS SINUS MENINGIOMA COGNITIVE IMPAIRMENT PHOTON RADIOTHERAPY PROTON THERAPY

Contacts and locations

Locations

CHU Grenoble-Alpes
NOT_YET_RECRUITING

Grenoble, France
Centre Antoine Lacassagne
NOT_YET_RECRUITING

Nice, France
Centre Francois Baclesse
RECRUITING

Caen, 14000, France
Centre Guillaume le Conquerant
NOT_YET_RECRUITING

Le Havre, France
Centre Léon Bérard
NOT_YET_RECRUITING

Lyon, France
Centre Paul Strauss
NOT_YET_RECRUITING

Strasbourg, France
Gustave Rousy
NOT_YET_RECRUITING

Villejuif, France
Hopital d'Instruction des Armées PERCY
NOT_YET_RECRUITING

Clamart, France
Hospices civils de Lyon
NOT_YET_RECRUITING

Lyon, France
Hôpital Pitié Salpétrière
NOT_YET_RECRUITING

Paris, France
IUCT
RECRUITING

Toulouse, France
Institut Curie
RECRUITING

Paris, France
Institut Curie
NOT_YET_RECRUITING

Saint-Cloud, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.